Primidone BE study for USFDA submission [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-04-09 05:54 (1591 d 13:28 ago) – Posting: # 18654
Views: 4,133

Dear All,

Till now, USFDA has not issued product specific bioequivalence recommendation to conduct the Primidone BE study. Any one could suggest, what to estimate in the Primidone BE study for USFDA submission, Whether required to estimate parent (Primidone) and metabolite Phenobarbital and phenylethylmalonamide (PEMA) or parent only?


Edit: Relax; see also this post #9. I deleted your other post which is less than two days old… [Helmut]

Complete thread:

UA Flag
 Admin contact
22,305 posts in 4,668 threads, 1,587 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Wednesday 19:23 CEST (Europe/Vienna)

There is no point in being precise when you don’t know
what you’re talking about.    attributed to John Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz